PRS
ALXN

Pinkerton Retirement Specialists’s Alexion Pharmaceuticals ALXN Stock Holding History

Pinkerton Retirement Specialists’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30
Closed -$4K – 542
2016
Q4 		$4K Hold
30
– – ﹤0.01% 476
2016
Q3 		$4K Hold
30
– – ﹤0.01% 487
2016
Q2 		$4K Buy
+30
New +$4.26K ﹤0.01% 486

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Pinkerton Retirement Specialists's ALXN Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of Alexion Pharmaceuticals (ALXN) in Q1 2017, closing a stake of 30 shares — an estimated $4K sold.

Pinkerton Retirement Specialists first reported a position in ALXN in Q2 2016 and held it in 3 quarters. The position peaked at $4K in Q4 2016. 561 funds tracked by Wall St. Rank hold ALXN as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining Alexion Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 30 Alexion Pharmaceuticals shares in Q1 2017, an estimated $4K.
  • Pinkerton Retirement Specialists first reported a position in Alexion Pharmaceuticals in Q2 2016 and held it in 3 quarters.
  • Pinkerton Retirement Specialists's Alexion Pharmaceuticals position peaked at $4K in Q4 2016.
  • 561 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.